Intravenous Golimumab in the Treatment of Juvenile Idiopathic Arthritis and Its Associated Uveitis.

Shawn KhanKhushi SaigalSohum ShethStephen Foster

Published in: Ocular immunology and inflammation (2024)

Intravenous golimumab proves to be efficacious and safe for inducing and sustaining remission in JIA and JIA-associated uveitis. Nonetheless, further robust studies with larger sample sizes are needed to substantiate our findings.

Keyphrases

juvenile idiopathic arthritis
disease activity
ankylosing spondylitis
ulcerative colitis
rheumatoid arthritis
high dose
systemic lupus erythematosus
low dose
combination therapy